IL-4 within the bone marrow: a key driver of lung tumorigenesis

Yoshimasa Tanaka
DOI: https://doi.org/10.1093/jleuko/qiae033
2024-03-12
Journal of Leukocyte Biology
Abstract:Interleukin-4 in bone marrow serves as a driver of lung cancer. Combining interleukin-4 receptor α chain blockade with immune checkpoint inhibitors has the potential for a novel superior cancer immunotherapy targeting the tumor microenvironment.
immunology,cell biology,hematology
What problem does this paper attempt to address?